Dr. Reddy's Laboratories Limited's latest marketcap:
As of 06/15/2025, Dr. Reddy's Laboratories Limited's market capitalization has reached $13.16 B. According to our data, Dr. Reddy's Laboratories Limited is the 1479th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | $13.16 B |
| Revenue (ttm) | $3.81 B |
| Net Income (ttm) | $661.75 M |
| Shares Out | 832 M |
| EPS (ttm) | $0.79 |
| Forward PE | 19.86 |
| Ex-Dividend Date | 07/30/2024 |
| Earnings Date | 07/28/2025 |
Dr. Reddy's Laboratories Limited's yearly market capitalization.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 06/15/2025 | $13.16 B | 2.45% | 1479 |
| 12/31/2024 | $13.17 B | 13.66% | 1353 |
| 12/29/2023 | $11.59 B | 34.54% | 1431 |
| 12/30/2022 | $8.61 B | -20.82% | 1703 |
| 12/31/2021 | $10.88 B | -8.18% | 1687 |
| 12/31/2020 | $11.85 B | 75.79% | 1400 |
| 12/31/2019 | $6.74 B | 7.74% | 746 |
| 12/31/2018 | $6.25 B | 0.47% | 685 |
| 12/29/2017 | $6.23 B | -19.41% | 740 |
| 12/30/2016 | $7.73 B | -2.05% | 567 |
Company Profile
About Dr. Reddy's Laboratories Limited
Dr. Reddy's Laboratories Limited is a globally integrated pharmaceutical company headquartered in Hyderabad, India. Established in 1984, the company operates through its subsidiaries across multiple segments, delivering a wide range of healthcare solutions.
Business Segments
- Global Generics: Manufactures and markets prescription and over-the-counter pharmaceutical products, including branded generics and biologics.
- Pharmaceutical Services and Active Ingredients (PSAI): Produces active pharmaceutical ingredients (APIs) and intermediates, along with contract research services.
- Others: Focuses on innovative therapies in oncology and inflammation, differentiated formulations, digital healthcare, and IT-enabled business support services.
Therapeutic Categories
The company provides products across key therapeutic areas, including:
- Gastro-intestinal
- Cardiovascular
- Anti-diabetic
- Dermatology
- Oncology
- Respiratory
- Stomatology
- Urology and Nephrology
Dr. Reddy's Laboratories continues to expand its global footprint, leveraging research, innovation, and high-quality manufacturing to serve patients worldwide.
Frequently Asked Questions
-
What is Dr. Reddy's Laboratories Limited's (RDY) current market cap?As of 06/15/2025, Dr. Reddy's Laboratories Limited (including the parent company, if applicable) has an estimated market capitalization of $13.16 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Dr. Reddy's Laboratories Limited (RDY) rank globally by market cap?Dr. Reddy's Laboratories Limited global market capitalization ranking is approximately 1479 as of 06/15/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.